Simvastatin, dosage and delivery system for supporting bone regeneration, an update review

作者: Mouetaz Kheirallah , Hassan Almeshaly

DOI: 10.1016/J.AJOMS.2015.10.005

关键词:

摘要: Abstract Objective The purpose of this review is to discuss the dosage, duration and carrier for simvastatin, summarize effects topical application directly or indirectly stimulating bone regeneration. Methods We have searched in Pubmed using keywords, dose response, regeneration, controlled-release delivery system. This search was complemented with a manual relevant articles cited among selected papers. written English published last 10 years. were revised depth, summarized. Results High simvastatin increases formation resorption, while low decreases furthermore it reported that high systemic administration will raise risk liver failure, kidney disease, other side effects. Local can bypass hepatic degradation statins achieve therapeutic concentrations avoid choice appropriate depend on release kinetics determined be best osteogenesis. Conclusion from carriers appears an attractive solution problem maintaining doses treat severe defects minimize undesired Locally delivered increase accelerate healing process bony defect. Another advantage local system stimulate new dose-dependent manner. Further evidence-based studies required determine promote

参考文章(58)
Shan Chen, Jing Ren, Lei Feng, Jun-Ying Yang, Sheng-Yan Zhang, Effects of simvastatin gel on bone regeneration in alveolar defects in miniature pigs. Chinese Medical Journal. ,vol. 124, pp. 3953- 3958 ,(2011)
Toru Suguro, Yoshinori Takakura, Takafumi Yoshikawa, Naohide Tomita, Hideyuki Aoki, Masato Sonobe, Koji Hattori, Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture. Bio-medical Materials and Engineering. ,vol. 15, pp. 261- 267 ,(2005)
Yasunori Ayukawa, Akira Okamura, Kiyoshi Koyano, Simvastatin promotes osteogenesis around titanium implants. Clinical Oral Implants Research. ,vol. 15, pp. 346- 350 ,(2004) , 10.1046/J.1600-0501.2003.01015.X
I Ross Garrett, Greg R Mundy, The role of statins as potential targets for bone formation. Arthritis Research & Therapy. ,vol. 4, pp. 237- 240 ,(2002) , 10.1186/AR413
Po-Chun Chang, Li Yen Chong, Alex S.M. Dovban, Lum Peng Lim, Jason C. Lim, Mark Yen-Ping Kuo, Chi-Hwa Wang, Sequential Platelet-Derived Growth Factor–Simvastatin Release Promotes Dentoalveolar Regeneration Tissue Engineering Part A. ,vol. 20, pp. 356- 364 ,(2014) , 10.1089/TEN.TEA.2012.0687
Ping Wang, Myositis and Rhabdomyolysis Associated With Concurrent Use of Simvastatin and Nefazodone JAMA: The Journal of the American Medical Association. ,vol. 277, pp. 296- 297 ,(1997) , 10.1001/JAMA.1997.03540280034021
Kerem Başarır, Bülent Erdemli, Alp Can, Esra Erdemli, Tuğba Zeyrek, Osseointegration in arthroplasty: can simvastatin promote bone response to implants? International Orthopaedics. ,vol. 33, pp. 855- 859 ,(2009) , 10.1007/S00264-007-0490-Y
Kyumin Whang, Jonathan McDonald, Ambereen Khan, Neera Satsangi, A novel osteotropic biomaterial OG-PLG: Synthesis and in vitro release Journal of Biomedical Materials Research Part A. ,vol. 74, pp. 237- 246 ,(2005) , 10.1002/JBM.A.30309
Yoon Shin Park, Allan E. David, Kyung Min Park, Chia-Ying Lin, Khoi D. Than, Kyuri Lee, Jun Beom Park, Inho Jo, Ki Dong Park, Victor C. Yang, Controlled Release of Simvastatin from In situ Forming Hydrogel Triggers Bone Formation in MC3T3-E1 Cells The AAPS Journal. ,vol. 15, pp. 367- 376 ,(2013) , 10.1208/S12248-012-9442-6
Marta Monjo, Marina Rubert, Johan Caspar Wohlfahrt, Hans Jacob Rønold, Jan Eirik Ellingsen, Staale Petter Lyngstadaas, In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects. Acta Biomaterialia. ,vol. 6, pp. 1405- 1412 ,(2010) , 10.1016/J.ACTBIO.2009.09.027